NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for October 20111. Global derivatives average daily volume (“ADV”) of 8.2 million contracts in October 2011 increased 9.1% versus the prior year, driven by an 18.7% increase in U.S. options ADV. Cash equities ADV in October 2011 were stronger, with European cash trading ADV increasing 21.0% and U.S. cash trading ADV increasing 5.6% from October 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in October 2011 of 8.2 million contracts increased 9.1% compared to October 2010, but decreased 13.9% from September 2011 levels.
• NYSE Euronext European derivatives products ADV in October 2011 of 3.4 million contracts decreased 3.8% compared to October 2010 and decreased 29.0% from September 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 5.2% compared to October 2010 and decreased 19.9% from September 2011.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.7 million contracts in October 2011 increased 18.7% compared to October 2010 levels and increased 2.0% from September 2011. NYSE Euronext’s U.S. options exchanges accounted for 27.3% of total U.S. consolidated equity options trading in October 2011, up from 25.9% in October 2010 and up from 26.8% recorded in September 2011.
• NYSE Liffe U.S. ADV of approximately 95,600 contracts increased from 12,900 contracts in October 2010, but decreased from 113,400 contracts in September 2011.
• NYSE Euronext European cash products ADV of 1.7 million transactions in October 2011 increased 21.0% compared to October 2010, but decreased 7.4% from September 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.5 billion shares in October 2011 increased 5.6% compared to October 2010, but decreased 2.4% compared to September 2011. NYSE Euronext’s Tape A matched market share in October 2011 was 33.9%, down from 35.2% in October 2010 and down from 36.3% in September 2011.
• There were a total of 21 trading days in Europe and the U.S. in October 2011 compared to 21 trading days in Europe and the U.S. in October 2010.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in October 2011 was 3.4 million futures and options contracts, a decrease of 3.8% from October 2010 and a decrease of 29.0% from September 2011.
• The 3.4 million in European derivatives futures and options contracts ADV in October 2011 consisted of 2.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.5 million contracts, or 14.9%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 5.2% compared to October 2010 and decreased 19.9% from September 2011.
• Year-to-date, European derivatives products ADV of 4.6 million contracts was 6.3% below prior year levels. The 4.6 million in futures and options contracts ADV year-to-date consisted of 3.4 million contracts executed through LIFFE CONNECT trading platform and 1.2 million contracts, or 25.1%, executed through Bclear.
• Total fixed income products ADV of 1.9 million contracts in October 2011 decreased 4.8% from October 2010 and decreased 25.4% from September 2011. Year-to-date, total fixed income products ADV of 2.4 million contracts was 1.8% below prior year levels.
• Total equity products (including Bclear) ADV of 1.4 million contracts in October 2011 decreased 2.7% compared to October 2010 and decreased 33.9% from September 2011. The 1.4 million contracts in equity products ADV consisted of 0.9 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 0.9 million contracts in individual equity products ADV consisted of 0.4 million in futures contracts, which represented a 6.1% increase compared to October 2010 and 0.5 million in options contracts, which represented a 18.1% decrease compared to October 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.2 million contracts was 11.6% below prior year levels.
• Total commodities products ADV of 80,000 contracts in October 2011 increased 4.3% compared to October 2010, but decreased 12.1% compared to September 2011. Year-to-date, total commodities product ADV of 83,000 contracts was 29.1% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.7 million contracts in October 2011 increased 18.7% compared to October 2010 and increased 2.0% compared to September 2011. Year-to-date, U.S. equity options ADV of 4.5 million contracts was 21.3% above prior year levels.
• Total U.S. consolidated equity options ADV increased 12.8% to 17.1 million contracts in October 2011 compared to October 2010 and increased 0.1% compared to September 2011. Year-to-date, U.S. consolidated equity options ADV of 17.2 million contracts was 21.3% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 27.3% of the total U.S. consolidated equity options trading in October 2011, up from 25.9% in October 2010 and up from 26.8% in September 2011.
• NYSE Liffe U.S. ADV of approximately 95,600 contracts increased from 12,900 contracts in October 2010, but decreased from 113,400 contracts in September 2011. Year-to-date, U.S. futures and futures options ADV of 79,600 contracts was 390.0% above prior year levels.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.7 million transactions in October 2011 increased 21.0% compared to October 2010, but decreased 7.4% compared to September 2011.
• Year-to-date, European cash products ADV of 1.8 million transactions was 18.5% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in October 2011 increased 5.6% to 2.5 billion shares compared to October 2010, but decreased 2.4% from September 2011.
• Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 12.5% from prior year levels.
• NYSE Euronext’s Tape A matched market share in October 2011 was 33.9%, down from 35.2% in October 2010 and down from 36.3% in September 2011.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 401 million shares in October 2011 increased 32.6% compared to October 2010, but decreased 4.7% compared to September 2011.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 332 million shares was 4.3% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (“SEC”) that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

 

NYSE Euronext

Monthly Volume Summary

                            Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited; contracts in thousands) Oct-11 Oct-10 % Chg Oct-11 Oct-10 % Chg YTD 2011

% Chg vs.YTD 2010

YTD 2011

% Chg vs.YTD 2010

  Number of Trading Days - European Markets 21 21 21 21 214 214 Number of Trading Days - U.S. Markets 21 21 21 21 210 210   European Derivatives Products 3,415 3,548 -3.8 % 71,706 74,502 -3.8 % 4,621 -6.3 % 988,821 -5.9 % of which Bclear 508 482 5.5 % 10,669 10,116 5.5 % 1,161 -15.9 % 248,387 -15.6 %   Total Fixed Income Products 1,901 1,997 -4.8 % 39,917 41,934 -4.8 % 2,350 -1.8 % 502,867 -1.3 %   Short Term Interest Rate Products 1,758 1,880 -6.5 % 36,918 39,485 -6.5 % 2,209 -3.0 % 472,722 -2.5 % Medium and Long Term Interest Rate Products 1 143 117 22.4 % 2,999 2,450 22.4 % 141 21.1 % 30,145 21.7 %   Total Equity Products 2 1,434 1,475 -2.7 % 30,117 30,965 -2.7 % 2,188 -11.6 % 468,151 -11.2 %   Individual Equity Products 876 969 -9.7 % 18,391 20,355 -9.7 % 1,596 -14.2 % 341,620 -13.8 % Futures 360 340 6.1 % 7,566 7,132 6.1 % 994 -15.3 % 212,735 -14.9 % Options 515 630 -18.1 % 10,825 13,223 -18.1 % 602 -12.3 % 128,884 -11.9 % Equity Index Products 558 505 10.5 % 11,727 10,610 10.5 % 591 -3.6 % 126,531 -3.1 %   of which Bclear 508 482 5.5 % 10,669 10,116 5.5 % 1,161 -15.9 % 248,387 -15.6 % Individual Equity Products 438 412 6.3 % 9,202 8,658 6.3 % 1,080 -16.0 % 231,078 -15.6 % Futures 357 337 6.2 % 7,505 7,068 6.2 % 978 -16.4 % 209,272 -16.0 % Options 81 76 6.7 % 1,697 1,590 6.7 % 102 -11.6 % 21,806 -11.2 % Equity Index Products 70 69 0.6 % 1,467 1,459 0.6 % 81 -15.5 % 17,308 -15.2 %   Commodity Products 80 76 4.3 % 1,672 1,603 4.3 % 83 29.1 % 17,803 29.7 %   U.S. Derivatives Products   Equity Options 3   NYSE Euronext Options Contracts 4,678 3,942 18.7 % 98,242 82,791 18.7 % 4,469 21.3 % 938,410 21.8 % Total Consolidated Options Contracts 17,147 15,199 12.8 % 360,081 319,169 12.8 % 17,183 21.3 % 3,608,406 21.9 %   NYSE Group Share of Total 27.3 % 25.9 % 27.3 % 25.9 % 26.0 % 0.0 % 26.0 % 0.0 %   NYSE Liffe U.S.   Futures and Futures Options Volume* 95.6 12.9 638.8 % 2,008 272 638.8 % 79.6 390.0 % 17,108.9 404.0 %   European Cash Products (trades in thousands) 1,743 1,441 21.0 % 36,600 30,252 21.0 % 1,752 18.5 % 374,867 19.0 %   Equities 1,675 1,382 21.2 % 35,167 29,027 21.2 % 1,683 18.6 % 360,251 19.1 % Exchange-Traded Funds 23 17 34.5 % 473 352 34.5 % 21 17.4 % 4,461 17.9 % Structured Products 41 36 13.4 % 862 760 13.4 % 42 18.9 % 9,085 19.5 % Bonds 5 5 -14.0 % 97 113 -14.0 % 5 -12.8 % 1,069 -12.4 %   U.S. Cash Products (shares in millions) 5 2,496 2,364 5.6 % 52,418 49,646 5.6 % 2,349 -12.5 % 493,269 -12.1 %   NYSE Listed (Tape A) Issues 4   Handled Volume 5 1,726 1,703 1.3 % 36,238 35,755 1.3 % 1,654 -15.0 % 347,298 -14.6 % Matched Volume 6 1,632 1,612 1.2 % 34,277 33,857 1.2 % 1,568 -14.1 % 329,199 -13.6 % Total NYSE Listed Consolidated Volume 4,810 4,577 5.1 % 101,017 96,126 5.1 % 4,473 -10.6 % 939,433 -10.2 %   Share of Total Consolidated Volume Handled Volume 5 35.9 % 37.2 % -1.3 % 35.9 % 37.2 % -1.3 % 37.0 % -1.9 % 37.0 % -1.9 % Matched Volume 6 33.9 % 35.2 % -1.3 % 33.9 % 35.2 % -1.3 % 35.0 % -1.4 % 35.0 % -1.4 %   NYSE Arca & Amex (Tape B) Listed Issues   Handled Volume 5 454 346 31.0 % 9,528 7,276 31.0 % 391 -2.2 % 82,110 -1.7 % Matched Volume 6 410 315 30.3 % 8,616 6,610 30.3 % 352 -1.9 % 73,955 -1.4 % Total NYSE Arca & Amex Listed Consolidated Volume 1,763 1,268 39.0 % 37,013 26,628 39.0 % 1,509 0.1 % 316,962 0.6 %   Share of Total Consolidated Volume Handled Volume 5 25.7 % 27.3 % -1.6 % 25.7 % 27.3 % -1.6 % 25.9 % -0.6 % 25.9 % -0.6 % Matched Volume 6 23.3 % 24.8 % -1.5 % 23.3 % 24.8 % -1.5 % 23.3 % -0.5 % 23.3 % -0.5 %   Nasdaq Listed (Tape C) Issues   Handled Volume 5 317 315 0.6 % 6,653 6,615 0.6 % 304 -10.3 % 63,861 -9.8 % Matched Volume 6 275 272 1.4 % 5,785 5,705 1.4 % 262 -8.4 % 54,999 -7.9 % Total Nasdaq Listed Consolidated Volume 2,092 2,015 3.8 % 43,923 42,318 3.8 % 2,079 -8.3 % 436,514 -7.8 %   Share of Total Consolidated Volume Handled Volume 5 15.1 % 15.6 % -0.5 % 15.1 % 15.6 % -0.5 % 14.6 % -0.3 % 14.6 % -0.3 % Matched Volume 6 13.2 % 13.5 % -0.3 % 13.2 % 13.5 % -0.3 % 12.6 % 0.0 % 12.6 % 0.0 %   Exchange-Traded Funds 5,7   Handled Volume 5 443 332 33.4 % 9,311 6,980 33.4 % 369 -4.4 % 77,433 -3.9 % Matched Volume 6 401 302 32.6 % 8,420 6,348 32.6 % 332 -4.3 % 69,701 -3.9 % Total ETF Consolidated Volume 1,759 1,231 43.0 % 36,942 25,842 43.0 % 1,450 -2.6 % 304,516 -2.2 %   Share of Total Consolidated Volume Handled Volume 5 25.2 % 27.0 % -1.8 % 25.2 % 27.0 % -1.8 % 25.4 % -0.5 % 25.4 % -0.5 % Matched Volume 6 22.8 % 24.6 % -1.8 % 22.8 % 24.6 % -1.8 % 22.9 % -0.4 % 22.9 % -0.4 %

 

1   Data includes currency products. 2 Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. 3 Includes trading in U.S. equity options contracts, not equity-index options. 4 Includes all volume executed in NYSE Group crossing sessions. 5

Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to

and executed at an external market center. NYSE Arca routing includes odd-lots.

6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 7 Data included in previously identified categories. *

ADVs calculated with the appropriate number of NYSE Liffe U.S. trading.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.